Sign inGet started

Brudnick Richard

Insider CIK 1692359 · CDAK See Remarks · BIVV EVP, Business Development · SRRK Director · PRME Chief Business Officer · VNRX Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
SRRK Scholar Rock Holding Corp A Award deriv2026-06-042026-06-084,310— $04,310SEC↗
SRRK Scholar Rock Holding Corp A Award2026-06-042026-06-086,839— $021,896SEC↗
SRRK Scholar Rock Holding Corp S Sale2025-05-292025-05-304,675$29.63 $138.5K16,457SEC↗
SRRK Scholar Rock Holding Corp S Sale2025-05-292025-05-301,400$30.00 $42.0K15,057SEC↗
SRRK Scholar Rock Holding Corp A Award deriv2025-05-222025-05-239,206— $09,206SEC↗
SRRK Scholar Rock Holding Corp A Award2025-05-222025-05-237,632— $021,132SEC↗
PRME Prime Medicine, Inc. P Buy2025-05-202025-05-2220,000$1.19 $23.8K20,000SEC↗
PRME Prime Medicine, Inc. A Award deriv2025-02-272025-03-03225,000— $0225,000SEC↗
PRME Prime Medicine, Inc. A Award deriv2024-12-052024-12-0919,300— $057,900SEC↗
SRRK Scholar Rock Holding Corp A Award deriv2024-06-272024-07-0118,000— $018,000SEC↗
SRRK Scholar Rock Holding Corp A Award2024-06-272024-07-0113,500— $013,500SEC↗
PRME Prime Medicine, Inc. A Award deriv2024-05-172024-05-2119,300— $038,600SEC↗
PRME Prime Medicine, Inc. A Award deriv2024-02-212024-02-23135,747— $0135,747SEC↗
SRRK Scholar Rock Holding Corp A Award deriv2023-04-062023-04-1056,000— $056,000SEC↗
PRME Prime Medicine, Inc. A Award deriv2023-03-312023-04-04135,747— $0135,747SEC↗
VNRX VOLITIONRX LTD A Award2023-01-122023-01-135,625— $027,936SEC↗
VNRX VOLITIONRX LTD A Award2022-10-132022-10-142,625— $022,311SEC↗
VNRX VOLITIONRX LTD A Award deriv2022-06-232022-06-245,613— $08,635SEC↗
VNRX VOLITIONRX LTD A Award2022-06-232022-06-243,046— $019,686SEC↗
VNRX VOLITIONRX LTD A Award deriv2022-04-072022-04-083,022— $03,022SEC↗
VNRX VOLITIONRX LTD A Award2022-04-072022-04-081,640— $016,640SEC↗
CDAK Codiak BioSciences, Inc. A Award deriv2022-02-162022-02-1810,850— $010,850SEC↗
CDAK Codiak BioSciences, Inc. A Award deriv2022-02-162022-02-1816,275— $016,275SEC↗
CDAK Codiak BioSciences, Inc. A Award deriv2022-01-192022-01-218,400— $08,400SEC↗
CDAK Codiak BioSciences, Inc. A Award deriv2022-01-192022-01-2141,000— $041,000SEC↗
VNRX VOLITIONRX LTD A Award2021-03-252021-03-2915,000— $015,000SEC↗
CDAK Codiak BioSciences, Inc. A Award deriv2021-01-222021-01-2631,000— $031,000SEC↗
BIVV Bioverativ Inc. D To issuer deriv2018-03-082018-03-0829,797— $00SEC↗
BIVV Bioverativ Inc. D To issuer deriv2018-03-082018-03-0859,595— $00SEC↗
BIVV Bioverativ Inc. D To issuer deriv2018-03-082018-03-0814,899— $00SEC↗
BIVV Bioverativ Inc. D To issuer deriv2018-03-082018-03-0831,818— $00SEC↗
BIVV Bioverativ Inc. D To issuer deriv2018-03-082018-03-087,489— $00SEC↗
BIVV Bioverativ Inc. D To issuer2018-03-082018-03-0822,952— $00SEC↗
BIVV Bioverativ Inc. F Tax w/h2018-02-232018-02-26924$104.74 $96.8K22,952SEC↗
BIVV Bioverativ Inc. F Tax w/h2018-02-222018-02-261,419$104.30 $148.0K23,876SEC↗
BIVV Bioverativ Inc. M Exercise deriv2018-02-142018-02-153,744— $07,489SEC↗
BIVV Bioverativ Inc. F Tax w/h2018-02-142018-02-151,137$103.52 $117.7K25,295SEC↗
BIVV Bioverativ Inc. M Exercise2018-02-142018-02-153,744— $026,432SEC↗
BIVV Bioverativ Inc. A Award deriv2018-01-312018-02-0231,818— $031,818SEC↗
BIVV Bioverativ Inc. F Tax w/h2017-02-282017-03-0266$43.42 $2.9K23,788SEC↗
BIVV Bioverativ Inc. A Award2017-02-282017-03-0227,376— $027,633SEC↗
BIVV Bioverativ Inc. F Tax w/h2017-02-282017-03-0251$43.42 $2.2K27,582SEC↗
BIVV Bioverativ Inc. F Tax w/h2017-02-282017-03-0222$49.56 $1.1K27,560SEC↗
BIVV Bioverativ Inc. F Tax w/h2017-02-282017-03-0245$47.76 $2.1K27,515SEC↗
BIVV Bioverativ Inc. F Tax w/h2017-02-282017-03-02939$43.42 $40.8K26,576SEC↗
BIVV Bioverativ Inc. F Tax w/h2017-02-282017-03-02411$49.56 $20.4K26,165SEC↗
BIVV Bioverativ Inc. F Tax w/h2017-02-282017-03-02837$47.76 $40.0K25,328SEC↗
BIVV Bioverativ Inc. F Tax w/h2017-02-282017-03-021,100$43.42 $47.8K22,688SEC↗
BIVV Bioverativ Inc. F Tax w/h2017-02-282017-03-02681$47.76 $32.5K23,854SEC↗
BIVV Bioverativ Inc. F Tax w/h2017-02-282017-03-02339$49.56 $16.8K24,535SEC↗
BIVV Bioverativ Inc. F Tax w/h2017-02-282017-03-02429$43.42 $18.6K24,874SEC↗
BIVV Bioverativ Inc. F Tax w/h2017-02-282017-03-0225$43.42 $1.1K25,303SEC↗
BIVV Bioverativ Inc. A Award deriv2017-02-142017-02-1629,744— $029,744SEC↗
BIVV Bioverativ Inc. A Award deriv2017-02-142017-02-1611,233— $011,233SEC↗
BIVV Bioverativ Inc. A Award deriv2017-02-142017-02-1659,488— $059,488SEC↗
BIVV Bioverativ Inc. A Award deriv2017-02-142017-02-1614,872— $014,872SEC↗
BIVV Bioverativ Inc. A Award deriv2017-02-142017-03-2759,595— $059,595SEC↗
BIVV Bioverativ Inc. A Award deriv2017-02-142017-03-2729,797— $029,797SEC↗
BIVV Bioverativ Inc. A Award deriv2017-02-142017-03-2714,899— $014,899SEC↗